Substituted imidazopyridines and the use thereof

US9150580B2 · kind B2 · utility

Assignees

• Bayer Intellectual Property GmbH · DE
• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Markus Follmann
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Alexander Straub · Wuppertal, DE
• Jens Ackerstaff · Mülheim an der Ruhr, DE
• Nils Griebenow · Milford, US
• Andreas Knorr · Erkrath, DE
• Frank Wunder · Wuppertal, DE
• Volkhart Min-Jian Li · Velbert, DE

Key dates

• Filing date: May 2, 2012
• Grant date: Oct 6, 2015
• Expiry date: May 2, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted imidazopyridazines having the following formula (I):to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases and to their use for production of medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.